Continuing Education Credits
At the conclusion of DIA 2017, participants should be able to:
- Compare the current regional regulatory and public policy environment pertaining to pharmaceuticals and related products
- Discuss the regulatory and economic factors that impact the global biopharmaceutical industry
- Recognize the challenges facing regulatory agencies and industry in research study design and statistical methodology
- Identify relevant data, document, and systems standards and integration approaches; explain their impact on quality and end to end efficiency in data collection, management, submission, and approval processes for medical products
- Describe the current and future scope of innovative technology, including wearables and other mobile devices, in the generation and collection of electronic source data in clinical research and post-market assessment to improve patient outcomes
- Discuss the role of big data and analytics, their applications throughout the product life cycle, and their ethical, legal, and security implications for patient data
- Identify legal, advertising, and marketing issues related to providing product information
- Apply principles of risk assessment and management to development and post-market phases of new health care products
- Summarize issues in safety reporting and data analysis regarding adverse events
- Distinguish regional approaches to integration of evidence-based medicine and comparative effectiveness research into health care decision making
- Describe current issues in designing and implementing clinical trials, including patient recruitment, site selection and management of multiregional clinical trials
- Discuss the evolving role of medical affairs in the evolving medical product development landscape
- Identify current opportunities and challenges in the area of personalized medicine for disease treatment
- Examine ways to provide appropriate support to the clinical trial process that will ultimately impact patient care
Specific learning objectives for each offering are found on the DIA 2017 website under the program description details and will be shown in all meeting rooms.
Select tutorials and program offerings (including sessions, forums, workshops, symposia) may be approved for AMA PRA Category 1 Credits™, pharmacy nursing contact hours, or International Association for Continuing Education and Training continuing education units (CEUs). Continuing education credit information will be clearly identified in the final program and on the DIA 2017 website with the statement CME, Pharmacy, Nursing and IACET credits.
Accreditation Council for Continuing Medical Education (ACCME)
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine (PIM) and the Drug Information Association (DIA). PIM is accredited by the ACCME to provide continuing medical education for physicians.
Accreditation Council for Pharmacy Education (ACPE)
DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
American Nurses Credentialing Center (ANCC)
International Association for Continuing Education and Training (IACET)
DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).
Continuing Legal Education
For attorneys who would like to receive continuing legal education credits for attending DIA 2016, please complete your state’s application for credit and submit accordingly. If you require additional information, please contact CE@DIAglobal.org
Unless otherwise disclosed, DIA acknowledges that the statements made by speakers are their own opinion and not necessarily that of the organization they represent, or that of the DIA. Speakers, agenda, and CE information are subject to change without notice.
Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.
Disclosure of Conflicts of Interest
The Postgraduate Institute for Medicine (PIM) and DIA require instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM and DIA for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Disclosure statements will be included in the activity materials.
Americans with Disabilities Act (ADA)
Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.
Read DIA’s Grievance Policy.